Clinical Trial

A Study of SGB-9768 in Adult Healthy Volunteers

Unknown Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2025 (before its estimated May 3, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a randomized, double-blind, placebo-controlled single ascending dose study of SGB-9768 in healthy volunteers. The purpose is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered SGB-9768.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06501573
Lead Sponsor Suzhou Sanegene Bio Inc.
Conditions Healthy Volunteer
Enrollment 37 participants
Start Date 2024-08-06
Primary Completion 2025-05-03 (estimated)
Study Completion 2025-10-17 (estimated)
Updated on ClinicalTrials.gov 2025-01-22